Skip to content

Effects of Hemerocallis fulva derived component Containing food on Sleep quality for Research concerning

Effects of Hemerocallis fulva derived component Containing food on Sleep quality for Research concerning - Effects of Hemerocallis fulva derived component Containing food on Sleep quality for Research concerning

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000035299
Enrollment
32
Registered
2019-01-08
Start date
2018-12-24
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

N/A (Healthy adults)

Interventions

Oral intake of the test foods (5 tablets in a day
2 weeks) Oral intake of the placebo foods (5 tablets in a day

Sponsors

Nahanishi Clinic.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: [1]Age 20-60, Not person suffering from a disease, desk worker aware of mild sleep disturbance (eg, tired, poor sleeping, shallow sleep etc.) [2]Bedtime and wake-up time are regular, bedtime is before 24 o'clock, sleeping habits generally over 4 hours [3]Work schedule: daytime, work 5 days a week, closed twice a week [4]BMI:<25

Exclusion criteria

Exclusion criteria: [1]Individuals who are Suspected sleep apnea syndrome (SAS) or during treatment and medical history [2]Individuals Who are Nocturia, benign prostatic hyperplasia, person with overactive bladder, suspected [3]Those who have an existing medical condition such as liver disease, renal disease, cardiovascular disease, digestive organ disease, respiratory disease, blood system disease, autoimmune disease, endocrine system disease and metabolic disease [4]Individuals who are medical allergy or serious food allergy [5]Individuals who are pregnant, those who intend to become pregnant during the test period, those who are breastfeeding [6]Individuals who are regularly use medicines, quasi-drugs, supplements, etc. relating to stress improvement and sleep improvement [7]Individuals who excessively take alcohol(expressed in an amounnt of alcohol: over 60g/day) [8]Individuals judged inappropriate for the study by the principal and research director

Design outcomes

Primary

MeasureTime frame
[1]Sleep stage analysis of sleep EEG [2]Pittsburgh Sleep Questionnaire (PSQI-J) [3]OSA sleep questionnaire

Secondary

MeasureTime frame
*Secondary outcomes [1]Physical condition change diary [2]Lifestyle questionnaire *Safety [1]Adverse events and side effects [2]Blood test [3]body weight [4]blood pressure [5]BMI

Countries

Japan

Contacts

Public ContactMasaki Matayoshi

Okinawa TLO Co., Ltd. Not Division

nemuri@okinawa-tlo.com098-895-1701

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026